Home > Clinical Trials

Saved trials

Completed
NCT00311155
Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
694 Enrollment(s)
40 Study location(s)
Interventional (Phase IV)
Essential Hypertension
Completed
NCT00214604
Type III Dysbetalipoproteinemia
30 Enrollment(s)
2 Study location(s)
Interventional (Phase III)
Hyperlipoproteinemia Type III
Completed
NCT01155765
Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis
70 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Hemodialysis
Chronic Renal Failure
Completed
NCT00356135
Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
139 Enrollment(s)
9 Study location(s)
Interventional (Phase II)
Coronary Arteriosclerosis
Acute Coronary Syndrome
Completed
NCT00151827
Olmesartan Medoxomil in Hypertension and Renal Impairment
393 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Renal Impairment
Completed
NCT01011127
Different Metabolic Effects of Statins
0 Enrollment(s)
1 Study location(s)
Observational
Hypercholesterolemia
Completed
NCT00134160
OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
1,000 Enrollment(s)
2 Study location(s)
Interventional (Phase IV)
Hypertension
Cardiovascular Diseases
Completed
NCT00914524
Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy
49 Enrollment(s)
0 Study location(s)
Interventional (Phase II)
Chronic Glomerulonephritis
Diabetic Nephropathy